CI
SRRA

Cowen Inc’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Cowen Inc’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$28K Sell
1,250
-625
-33% -$30.3K ﹤0.01% 357
2019
Q1 		$128K Buy
1,875
+625
+50% +$40.1K 0.01% 221
2018
Q4 		$66K Buy
+1,250
New +$79.8K 0.01% 264

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cowen Inc's SRRA Position: Q2 2019 in Review

Cowen Inc reduced its Sierra Oncology, Inc. Common Stock (SRRA) stake by 33% in Q2 2019, selling an estimated $30.3K and leaving 1,250 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Cowen Inc first reported a position in SRRA in Q4 2018 and has held it in 3 quarters since. The position peaked at $128K in Q1 2019. 49 funds tracked by Wall St. Rank hold SRRA as of Q2 2019.

  • Cowen Inc held 1,250 shares of Sierra Oncology, Inc. Common Stock worth $28K as of Q2 2019.
  • Cowen Inc sold 625 Sierra Oncology, Inc. Common Stock shares in Q2 2019, an estimated $30.3K.
  • Sierra Oncology, Inc. Common Stock made up ﹤0.01% of Cowen Inc's portfolio in Q2 2019, its #357 holding.
  • Cowen Inc first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2018 and has held it in 3 quarters since.
  • Cowen Inc's Sierra Oncology, Inc. Common Stock position peaked at $128K in Q1 2019.
  • 49 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.